A more contagious coronavirus variant is on the rise in the United States and could become dominant in hot spots like Florida and Southern California “within a few weeks,” according to a testing company that has helped identify the largest share of variant cases in the US.
President Joe Biden’s first full day in office Thursday focused on getting the Covid-19 pandemic under control, rolling out his national strategy that includes several executive actions related to vaccinations and testing in hopes of moving the federal response in a different direction.
With two vaccines being administered in the US, where do you stand in line? Will you have to pay anything? What can you do after you’re vaccinated? Here’s what you need to know.
As several COVID-19 vaccines head toward authorization in the U.S., questions about vaccine access are coming up, too: Who is slated to get the vaccine first? Why? And, when can I get one?
It is not yet clear what impact vaccines may have on transmission
“Long Covid” – the long-lasting impact of coronavirus infection – may be affecting people in four different ways, according to a review.
Nine in ten coronavirus patients reported experiencing side-effects such as fatigue, psychological after-effects and loss of smell and taste after they recovered from the disease, according to a preliminary study by South Korea.
Scientists at the University of Pittsburgh School of Medicine have isolated “the smallest biological molecule” that “completely and specifically neutralizes” the virus that causes COVID-19.
A handful of the dozens of experimental COVID-19 vaccines in human testing have reached the last and biggest hurdle — looking for the needed proof that they really work as a U.S. advisory panel suggested Tuesday a way to ration the first limited doses once a vaccine wins approval.
In late January, researchers at BenevolentAI, an artificial intelligence startup in central London, turned their attention to the coronavirus.